Successful Desensitization with Crizotinib after Crizotinib-induced Liver Injury in ROS1-rearranged Lung Adenocarcinoma

Crizotinib has been approved for patients with advanced lung adenocarcinoma harboring rearrangements of the c-ROS-1 (ROS1) and anaplastic lymphoma kinase (ALK) genes. We report a patient with ROS1-rearranged lung adenocarcinoma who developed a crizotinib-induced mixed/cholestatic type of liver injur...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Intern Med
Autors principals: Ota, Takayo, Masuda, Noriyuki, Matsui, Kaoru, Yamada, Takao, Tanaka, Noriko, Fujimoto, Shunsuke, Fukuoka, Masahiro
Format: Artigo
Idioma:Inglês
Publicat: The Japanese Society of Internal Medicine 2019
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6794186/
https://ncbi.nlm.nih.gov/pubmed/31178493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.2554-18
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars